Clinical Trial Update: Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor [Phase 3]

View source ↗

Summary

Phase 3 trial update examining whether monitoring drug levels in the blood can guide therapy for HIV-infected patients taking a protease inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED